• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytes.

作者信息

Frohman E M, Vayuvegula B, van den Noort S, Gupta S

机构信息

Department of Anatomy and Neurobiology, California College of Medicine, University of California, Irvine 92717.

出版信息

J Neuroimmunol. 1988 Jan;17(2):89-101. doi: 10.1016/0165-5728(88)90017-3.

DOI:10.1016/0165-5728(88)90017-3
PMID:2826540
Abstract

Recent evidence that astrocytes can be induced to express the class II major histocompatability (MHC) antigens suggests that these cells may be involved in the development of intracerebral immune responses. The principal inducer of MHC class II antigen (Ia) expression is a soluble lymphokine, gamma-interferon (gamma-IFN). Normally astrocytes do not express significant levels of Ia antigens despite the fact that agents such as gamma-IFN may be present in the central nervous system (CNS). Here we report that a major neurotransmitter, norepinephrine (NE), inhibits, in a dose-response fashion, the ability of gamma-IFN to induce Ia antigen expression on cultured astrocytes derived from newborn BALB/c mice. This finding may indicate that the brain contains inhibitory modulators that serve to prevent the up-regulation of intracerebral immune responsiveness.

摘要

相似文献

1
Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytes.
J Neuroimmunol. 1988 Jan;17(2):89-101. doi: 10.1016/0165-5728(88)90017-3.
2
Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms.去甲肾上腺素通过β-2-肾上腺素能信号转导机制抑制培养的星形胶质细胞上γ-干扰素诱导的主要组织相容性复合体II类(Ia)抗原表达。
Proc Natl Acad Sci U S A. 1988 Feb;85(4):1292-6. doi: 10.1073/pnas.85.4.1292.
3
Vasoactive intestinal polypeptide inhibits the expression of the MHC class II antigens on astrocytes.
J Neurol Sci. 1988 Dec;88(1-3):339-46. doi: 10.1016/0022-510x(88)90230-4.
4
Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes.β干扰素和γ干扰素对培养的人胎儿星形胶质细胞中主要组织相容性复合体抗原和细胞间黏附分子-1表达的不同影响。
Neurology. 1995 Feb;45(2):367-73. doi: 10.1212/wnl.45.2.367.
5
Tetraethylammonium, a K+ channel blocker, inhibits interferon-gamma-induced major histocompatibility class II antigen (Ia) expression and DNA synthesis in rat astrocytes.
J Neuroimmunol. 1991 Jan;31(1):43-9. doi: 10.1016/0165-5728(91)90085-l.
6
Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-gamma and tumor necrosis factor-alpha.γ干扰素和肿瘤坏死因子-α对星形胶质细胞中II类主要组织相容性复合体mRNA表达的诱导与调节
J Neuroimmunol. 1990 Dec;30(2-3):189-200. doi: 10.1016/0165-5728(90)90103-t.
7
Induction of antigen presentation ability in purified cultures of astroglia by interferon-gamma.干扰素-γ对纯化培养的星形胶质细胞抗原呈递能力的诱导作用。
J Mol Cell Immunol. 1986;2(5):269-80.
8
Inducible expression of H-2 and Ia antigens on brain cells.H-2和Ia抗原在脑细胞上的诱导表达。
Nature. 1984;310(5979):688-91. doi: 10.1038/310688a0.
9
Interferon regulatory factor-1 is required for interferon-gamma-induced MHC class I genes in astrocytes.星形胶质细胞中γ干扰素诱导的MHC I类基因需要干扰素调节因子-1。
J Neuroimmunol. 2002 Jan;122(1-2):74-84. doi: 10.1016/s0165-5728(01)00467-2.
10
Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia.谷氨酸对星形胶质细胞和小胶质细胞上II类主要组织相容性复合体抗原的表达有不同的抑制作用。
J Immunol. 1992 Jun 1;148(11):3391-7.

引用本文的文献

1
Physical activity and glioblastoma: a paradigm shift in neuro-oncology therapy.体育活动与胶质母细胞瘤:神经肿瘤学治疗的范式转变
Front Oncol. 2025 Jul 30;15:1638060. doi: 10.3389/fonc.2025.1638060. eCollection 2025.
2
Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients.免疫治疗初治多发性硬化症患者中枢去甲肾上腺素转运体可利用性的变化。
Sci Rep. 2020 Sep 4;10(1):14651. doi: 10.1038/s41598-020-70732-5.
3
β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma.
β肾上腺素能受体调节胶质细胞瘤模型中的信号转导:促进β肾上腺素能受体-β-arrestin 支架介导的细胞外调节激酶 1/2 的激活可能被证明是治疗颅内和脊髓恶性肿瘤和神经外轴外癌的万能药。
Mol Biol Rep. 2020 Jun;47(6):4631-4650. doi: 10.1007/s11033-020-05427-1. Epub 2020 Apr 18.
4
Blood-brain barrier permeability and physical exercise.血脑屏障通透性与体力活动。
J Neuroinflammation. 2019 Jan 24;16(1):15. doi: 10.1186/s12974-019-1403-x.
5
Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.功能失调的感觉模态、蓝斑和基底前脑:促进认知和记忆衰退以及阿尔茨海默病神经病理发生的早期决定因素。
Neurotox Res. 2016 Oct;30(3):295-337. doi: 10.1007/s12640-016-9643-3. Epub 2016 Jun 23.
6
G protein-coupled receptors as therapeutic targets for multiple sclerosis.G 蛋白偶联受体作为多发性硬化症的治疗靶点。
Cell Res. 2012 Jul;22(7):1108-28. doi: 10.1038/cr.2012.87. Epub 2012 Jun 5.
7
Astrocyte, the star avatar: redefined.星形胶质细胞,星之化身:重新定义。
J Biosci. 2008 Sep;33(3):405-21. doi: 10.1007/s12038-008-0060-5.
8
Norepinephrine-mediated suppression of phagocytosis by wound neutrophils.去甲肾上腺素介导伤口中性粒细胞对吞噬作用的抑制。
J Surg Res. 2009 Apr;152(2):311-8. doi: 10.1016/j.jss.2008.05.001. Epub 2008 Jun 2.
9
HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide.HIV-1反式激活因子抑制小胶质细胞对β淀粉样肽的吞噬作用。
Int J Clin Exp Pathol. 2008 Jan 1;1(3):260-75.
10
Introduction: Anti-inflammatory Treatment of Childhood Asthma: Cromoglycate and Nedocromil as Non-steroidal Alternatives?引言:儿童哮喘的抗炎治疗:色甘酸盐和奈多罗米作为非甾体类替代药物?
Mediators Inflamm. 1994;3(7):S5. doi: 10.1155/S0962935194000670.